Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing efficacy and safety of bimatoprost 0.01% alone with travoprost 0.004% and timolol 0.5% in glaucoma or ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension has completed and resu…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 study evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension completed with results…
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 clinical trial assessing the safety and efficacy of a triple combination therapy in patients with primary open-angle glaucoma or ocu…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study [Phase 4]
A Phase 4, European multicenter, investigator-led trial comparing preservative-free bimatoprost and latanoprost on intraocular pressure and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: A Study of Bimatoprost 0.01% in the Clinical Setting
The document reports the completion of a clinical trial evaluating bimatoprost 0.01% for primary open-angle glaucoma and ocular hypertension…
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
Allergan-sponsored clinical trial of Simbrinza for open-angle glaucoma or ocular hypertension has completed. The provided snippet does not i…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, tolerability, and efficacy of LX7101 in subjects with primary open-angle glaucoma or ocula…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial comparing AZARGA to COSOPT in open-angle glaucoma or ocular hypertension has completed, providing comparative efficacy data.
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea
This completed Korean clinical trial evaluated the safety and efficacy of Ganfort (bimatoprost/timolol) ophthalmic solution. It enrolled pat…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma [Phase 4]
Phase 4 clinical trial assessing intraocular pressure reduction with Travoprost ophthalmic solution in normal tension glaucoma. Results have…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® [Phase 4]
Phase 4 trial comparing the efficacy and tolerability of TRAVATAN (travoprost) versus LUMIGAN (bimatoprost) in glaucoma and ocular hypertens…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure [Phase 4]
Phase 4 clinical trial update assessing central corneal thickness and 24-hour intraocular pressure fluctuations in open angle glaucoma and o…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. [Phase 1, Phase 2]
This clinical trial investigates whether magnetic therapy combined with seawater can reduce intraocular pressure in primary open-angle glauc…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Survey of Patients Taking IOP-Lowering Eye Drops
Completed clinical trial update detailing a survey of patients taking intraocular pressure-lowering eye drops for glaucoma or ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue [Phase 4]
Phase 4 clinical trial evaluating SIMBRINZA suspension as add-on therapy to a prostaglandin analogue in ocular hypertension and open-angle g…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
A completed clinical trial evaluating patients with primary open-angle glaucoma or ocular hypertension who switched to Lumigan UD monotherap…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: DE-111 Against Timolol Ophthalmic Solution 0.5% [Phase 3]
Phase 3 trial comparing DE-111 against Timolol ophthalmic solution 0.5% for open-angle glaucoma and ocular hypertension; results have been p…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% [Phase 3]
Phase 3 trial evaluating tafluprost 0.0015% alone and in combination with timolol 0.5% for open-angle glaucoma and ocular hypertension. Resu…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating DE-111 ophthalmic solution for open-angle glaucoma or ocular hypertension has been completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® [Phase 4]
Phase 4 clinical trial evaluating adding SIMBRINZA (brinzolamide and timolol) to TRAVATAN Z (travoprost) for ocular hypertension and open-an…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [Phase 3]
A Phase 3 trial comparing two glaucoma drugs over a 24-hour period has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 safety study of bimatoprost in patients with glaucoma or ocular hypertension has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
An observational study assessing patients with primary open-angle glaucoma or ocular hypertension who switched IOP-lowering therapies; study…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma [Phase 2]
A Phase 2 trial evaluating the hypotensive efficacy of AR-12286 ophthalmic solution (0.5% and 0.7%) in patients with Exfoliation Syndrome an…